Should we routinely treat patients with autoimmune/rheumatic diseases and chronic hepatitis B virus infection starting biologic therapies with antiviral agents? NO
2011 ◽
Vol 22
(6)
◽
pp. 576-581
◽
2011 ◽
Vol 22
(6)
◽
pp. 572-575
◽
1990 ◽
Vol 31
(2)
◽
pp. 90-97
◽
2000 ◽
Vol 15
(5 (Suppl.))
◽
pp. E71-E78
◽